| Etiology | Cumulating evidence indicates that classic adamantinomas derive from their osteofibrous dysplasia (OFD)-like counterparts.OFD and adamantinoma show common cytogenetic abnormalities (see below), and by immunohistochemistry, it has been shown that the epithelial component of adamantinoma is directly derived from the fibrous tissue. However, clinical aggressiveness among OFD, OFD-like adamantinoma and classic adamantinoma varies considerably, and many OFD-like lesions may never progress to classic adamantinoma. |
| Epidemiology | Adamantinomas are rare, they comprise 0.1-0.5% of primary bone tumors. The peak incidence is in the second and third decade. The youngest age group (up to 15 years) mainly includes patients with osteofibrous dysplasia (OFD)-like adamantinoma, whereas in older patients classic adamantinomas are predominant. |
| Clinics | At conventional radiography, typically a well-circumscribed, central or eccentric, (multi-)lobulated osteolytic lesion is seen. Multifocality in the tibia as well as ipsilateral fibula is regularly observed. MRI is essential for pre-operative staging of the tumor and planning surgical margins. The treatment for most cases wide en-bloc resection. Adamantinomas may display a protracted clinical behavior. Some tumors have radiologically proven to be present 30 years prior to histological diagnosis, whereas metastases may occur decades after local treatment. Recurrence rate after irradical surgery may be as high as 90%, whereas up to 25% of these patients may develop metastases. |
| Pathology | Two main subtypes of adamantinoma are recognized: OFD-like adamantinomas lack a clear histological epithelial component, and mainly consist of osteofibrous tissue, in which woven bone trabeculae are rimmed by osteoblasts. Keratin immunohistochemistry highlights individual or small aggregates of positive cells. Classic adamantinomas have abundant epithelium, which may be arranged in basaloid, tubular, squamoid, spindle-cell, of mixed differentiation. Recently, sarcomatous dedifferentiation of the epithelial component has been described. |
| |  |
| |
| Figure 1: Classic adamantinoma, hematoxylin and eosin, x 100. Strings of epithelial cells embedded in fibrous tissue. Figure 2: OFD-like adamantinoma, HE x 100. No epithelial cells are distinguishable in osteofibrous tissue. Figure 3: OFD-like adamantinoma, immunohistochemistry for pankeratin, x 100. Individual keratin-positive cells (same case as figure 2). |
| |
| Adamantinoma of long bone. An analysis of nine new cases with emphasis on metastasizing lesions and fibrous dysplasia-like changes. |
| Weiss SW, Dorfman HD. |
| Hum Pathol 1977; 8: 141-153. |
| PMID 852865 |
| |
| Adamantinoma of the appendicular skeleton--updated. |
| Moon NF, Mori H. |
| Clin Orthop 1986; 204: 215-237. |
| PMID 3514033 |
| |
| Morphologic diversity of long bone adamantinoma. The concept of differentiated (regressing) adamantinoma and its relationship to osteofibrous dysplasia. |
| Czerniak B, Rojas-Corona RR, Dorfman HD. |
| Cancer 1989; 64: 2319-2334. |
| PMID 2804923 |
| |
| Fibrous dysplasia vs adamantinoma of the tibia. Differentiation based on discriminant analysis of clinical and plain film findings. |
| Bloem JL, Van der Heul RO, Schuttevaer HM, Kuipers D. |
| Am J Roentgenol 1991; 156: 1017-1023. |
| PMID 2017924 |
| |
| Cortical osteofibrous dysplasia of long bone and its relationship to adamantinoma: A clinicopathologic study of 30 cases. |
| Sweet DE, Vinh TN, Devaney K. |
| Am J Surg Pathol 1992; 16: 282-290. |
| PMID 1599019 |
| |
| Adamantinoma of the long bones: keratin subclass immunoreactivity pattern with reference to its histogenesis. |
| Hazelbag HM, Fleuren GJ, Van den Broek LJCM, Taminiau AHM, Hogendoorn PCW. |
| Am J Surg Pathol 1993; 17: 1225-1233. |
| PMID 7694513 |
| |
| Clonal chromosomal abnormalities in osteofibrous dysplasia. Implications for histopathogenesis and its relationship with adamantinoma. |
| Bridge JA, Dembinski A, DeBoer J, Travis J, Neff JR. |
| Cancer 1994;73:1746-1752. |
| PMID 8156503 |
| |
| Adamantinoma of long bones. A clinicopathological study of thirty-two cases with emphasis on histological subtype, precursor lesion and biological behavior. |
| Hazelbag HM, Taminiau AHM, Fleuren GJ, Hogendoorn PCW. |
| J Bone Joint Surg [Am] 1994; 76A: 1482-1499. |
| PMID 7929496 |
| |
| DNA aberrations in the epithelial cell component of adamantinoma of long bones. |
| Hazelbag HM, Fleuren GJ, Cornelisse CJ, Van den Broek LJCM, Taminiau AHM, Hogendoorn PCW. |
| Am J Pathol 1995; 147: 1770-1779. |
| PMID 7495301 |
| |
| Adamantinoma of long bones. A histopathological and immunohistochemical study of 23 cases. |
| Jundt G, Remberger K, Roessner A, Schulz A, Bohndorf K. |
| Path Res Pract 1995; 191: 112-120. |
| PMID 7567680 |
| |
| Distribution of extracellular matrix components in adamantinoma of long bones suggests fibrous-to-epithelial transformation. |
| Hazelbag HM, Van den Broek LJCM, Fleuren GJ, Taminiau AHM, Hogendoorn PCW. |
| Hum Pathol 1997; 28: 183-188. |
| PMID 9023400 |
| |
| Cytogenetic analysis of adamantinoma of long bones. Further indications for a common histogenesis with osteofibrous dysplasia. |
| Hazelbag HM, Wessels JW, Mollevangers P, Van den Berg E, Molenaar WM, Hogendoorn PCW. |
| Cancer Genet Cytogenet 1997; 97 : 5-11. |
| PMID 9242211 |
| |
| Expression of growth factors and their receptors in adamantinoma of long bones and the implications for its histogenesis. |
| Bovee JVMG, Van den Broek LJCM, De Boer WI, Hogendoorn PCW. |
| J Pathol 1998; 184: 24-30. |
| PMID 9582523 |
| |
| Osteofibrous dysplasia-like adamantinoma of bone: a report of five cases with immunohistochemical and ultrastructural studies. |
| Kuruvilla G, Steiner GC. |
| Hum Pathol 1998; 29: 809-814. |
| PMID 9712421 |
| |
| Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift. |
| Bridge JA, Fidler ME, Neff JR et al. |
| Am J Surg Pathol 1999; 23: 159-165. |
| PMID 9989842 |
| |
| Trisomies 8 and 20 characterize a subgroup of benign fibrous lesions arising in both soft tissue and bone. |
| Bridge JA, Swarts SJ, Buresh C et al. |
| Am J Pathol 1999; 154: 729-733. |
| PMID 10079250 |
| |
| Expression of cytokeratin 1, 5, 14, 19 and transforming growth factors- beta1, beta2, beta3 in osteofibrous dysplasia and adamantinoma: A possible association of transforming growth factor-beta with basal cell phenotype promotion. |
| Maki M, Saitoh K, Kaneko Y, Fukayama M, Morohoshi T. |
| Pathol Int 2000; 50: 801-807. |
| PMID 11107052 |
| |
| Adamantinoma-like Ewing's sarcoma and Ewing's-like adamantinoma. The t(11;22), t(21;22) status. |
| Hauben E, Van den Broek LJCM, Van Marck E, Hogendoorn PCW. |
| J Pathol 2001; 195: 218-221. |
| PMID 11592101 |
| |
| Adamantinome des os longs: revue anatomo-clinique et liens avec la dysplasie osteofibreuse. |
| Hazelbag HM, Hogendoorn PCW. |
| Ann Pathol 2001; 21: 499-511. |
| PMID 11910937 |
| |
| Extra copies of chromosomes 7, 8, 12, 19, and 21 are recurrent in adamantinoma. |
| Kanamori M, Antonescu CR, Scott M et al. |
| J Mol Diagn 2001; 3: 16-21. |
| PMID 11227067 |
| |
| Adamantinoma. In: Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. |
| Hogendoorn PCW, Hashimoto H. |
| Lyon: IARC Press, 2002: 332-334. |
| |